Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Arvinas, Inc. (ARVN) And Encourages Shareholders to Reach Out — Neutral
ARVN Accesswire — May 14, 2025NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Arvinas, Inc. ("Arvinas" or "the Company") (NASDAQ:ARVN). Investors who purchased Arvinas securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ARVN.

Bronstein, Gewirtz & Grossman, LLC Is Investigating Wabash National Corporation (WNC) And Encourages Shareholders to Connect — Neutral
WNC Accesswire — May 14, 2025NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Wabash National Corporation ("Wabash" or "the Company") (NYSE:WNC). Investors who purchased Wabash securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/WNC.

Bronstein, Gewirtz & Grossman, LLC Encourages SelectQuote, Inc. (SLQT) Shareholders to Inquire about Securities Investigation — Neutral
SLQT Accesswire — May 14, 2025NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SelectQuote, Inc. ("SelectQuote" or "the Company") (NYSE:SLQT). Investors who purchased SelectQuote securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SLQT.

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against D-Wave Quantum Inc. (QBTS) And Encourages Shareholders to Reach Out — Neutral
QBTS Accesswire — May 14, 2025NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of D-Wave Quantum Inc. ("D-Wave" or "the Company") (NYSE:QBTS). Investors who purchased D-Wave securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/QBTS.

Bronstein, Gewirtz & Grossman, LLC Encourages Krispy Kreme, Inc. (DNUT) Investors to Inquire about Securities Investigation — Neutral
DNUT Accesswire — May 14, 2025NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Krispy Kreme, Inc. ("Krispy Kreme" or "the Company") (NASDAQ:DNUT). Investors who purchased Krispy Kreme securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/DNUT.

Iovance Biotherapeutics, Inc. (IOVA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation — Neutral
IOVA Accesswire — May 14, 2025NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Iovance Biotherapeutics, Inc. ("Iovance" or "the Company") (NASDAQ:IOVA). Investors who purchased Iovance securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IOVA.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ichor Holdings, Ltd. (ICHR) and Encourages Stockholders to Learn More About the Investigation — Neutral
ICHR Accesswire — May 14, 2025NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ichor Holdings, Ltd. ("Ichor" or "the Company") (NASDAQ:ICHR).

Cable One, Inc. (CABO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation — Neutral
CABO Accesswire — May 14, 2025NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cable One, Inc. ("Cable One" or "the Company") (NYSE:CABO). Investors who purchased Cable One securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CABO.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PTC Therapeutics, Inc. (PTCT) and Encourages Investors to Learn More About the Investigation — Neutral
PTCT Accesswire — May 14, 2025NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PTC Therapeutics, Inc. ("PTC" or "the Company") (NASDAQ:PTCT). Investors who purchased PTC securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PTCT.

Bronstein, Gewirtz & Grossman, LLC Encourages Jack in the Box Inc. (JACK) Stockholders to Inquire about Securities Investigation — Neutral
JACK Accesswire — May 14, 2025NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Jack in the Box Inc. ("Jack in the Box" or "the Company") (NASDAQ:JACK). Investors who purchased Jack in the Box securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/JACK.

Bronstein, Gewirtz & Grossman, LLC Encourages Amerant Bancorp Inc. (AMTB) Stockholders to Inquire about Securities Investigation — Neutral
AMTB Accesswire — May 14, 2025NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Amerant Bancorp Inc. ("Amerant" or "the Company") (NYSE:AMTB). Investors who purchased Amerant securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/AMTB.

Bronstein, Gewirtz & Grossman, LLC Is Investigating Myriad Genetics, Inc. (MYGN) And Encourages Stockholders to Connect — Neutral
MYGN Accesswire — May 14, 2025NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Myriad Genetics, Inc. ("Myriad Genetics, Inc." or "the Company") (NASDAQ:MYGN). Investors who purchased Myriad Genetics, Inc. securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/MYGN.

Bronstein, Gewirtz & Grossman, LLC Encourages Watsco, Inc. (WSO) Stockholders to Inquire about Securities Investigation — Neutral
WSO Accesswire — May 14, 2025NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Watsco, Inc. ("Watsco" or "the Company") (NYSE: WSO). Investors who purchased Watsco securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/WSO.

Bronstein, Gewirtz & Grossman, LLC Is Investigating Organon & Co. (OGN) And Encourages Investors to Connect — Neutral
OGN Accesswire — May 14, 2025NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Organon & Co. ("Organon" or "the Company") (NYSE: OGN). Investors who purchased Organon securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/OGN.

On Behalf of Agri-Tech Startup Zest Labs, Inc., Bartko Pavia's Patrick M. Ryan Obtains $222 Million Jury Verdict Against Walmart — Neutral
WMT Business Wire — May 14, 2025LITTLE ROCK, Ark.--(BUSINESS WIRE)-- #BartkoPavia--Bartko Pavia LLP trial team, led by Patrick M. Ryan, achieves a landmark victory for Zest Labs, Inc. against Walmart.

Bronstein, Gewirtz & Grossman, LLC Encourages EchoStar Corporation (SATS) Investors to Inquire about Securities Investigation — Neutral
SATS Accesswire — May 14, 2025NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of EchoStar Corporation ("EchoStar" or "the Company") (NASDAQ:SATS). Investors who purchased EchoStar securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SATS.

Super Micro stock surges after Saudi deal, upbeat rating and AI optimism — Positive
SMCI Invezz — May 14, 2025Shares of Super Micro Computer rallied sharply in early trading Wednesday, extending gains from the previous session, as a combination of favourable analyst coverage, a multibillion-dollar AI infrastructure deal, and improved geopolitical sentiment lifted investor confidence in the server maker. The stock opened more than 18% higher at $45.

Tesla reportedly forms committee to review CEO Elon Musk's pay package — Neutral
TSLA Proactive Investors — May 14, 2025Tesla Inc (NASDAQ:TSLA)'s board has formed a special committee to evaluate CEO Elon Musk's compensation, which could lead to a new stock options package, The Financial Times (FT) reported, citing people familiar with the matter. The committee comprises board chair Robyn Denholm and independent director Kathleen Wilson-Thompson, and was established to assess alternative ways to compensate Musk in the event his voided 2018 pay deal is not reinstated through appeal.

Enliven Therapeutics Announces Updated Positive Data from Phase 1 Clinical Trial of ELVN-001 in CML and Oral Presentation at the EHA 2025 Congress — Neutral
ELVN PRNewsWire — May 14, 2025Reported cumulative MMR rate of 44% (16 of 36) by 24 weeks with 26% (7 of 27) of patients achieving MMR by 24 weeks, which continues to compare favorably to precedent Phase 1 trials of approved BCR::ABL1 TKIs ELVN-001 continues to demonstrate a favorable safety and tolerability profile across all dose levels with 74 patients enrolled and a median treatment duration of ~26 weeks at cutoff Presentation at EHA will include updated data with additional patients and longer treatment duration Enliven will host a webcast and conference call on June 13 at 1:30 p.m. ET BOULDER, Colo.

Lilly Down 17% Since Q1 Results: Should You Buy the Dip in LLY Stock? — Positive
LLY Zacks Investment Research — May 14, 2025Despite its expensive valuation and declining estimates, we suggest investors hold LLY stock as the company boasts solid growth prospects.
